We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $4.08B
1-Year Est. Return 58.77%
This Fund
S&P 500
This Quarter Est. Return
-15.72%
1 Year Est. Return
+58.77%
3 Year Est. Return
+143.94%
5 Year Est. Return
+167.17%
10 Year Est. Return
+536.06%
AUM
$4.46B
AUM Growth
-$6B
Cap. Flow
-$4.51B
Cap. Flow %
-101.07%
Top 10 Hldgs %
21.21%
Holding
7,134
New
733
Increased
2,939
Reduced
2,324
Closed
739

Top Sells

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$411M
2
MSFT icon
Microsoft
MSFT
+$372M
3
AMZN icon
Amazon
AMZN
+$192M
4
TSLA icon
Tesla
TSLA
+$121M
5
GOOG icon
Alphabet (Google) Class C
GOOG
+$111M

Sector Composition

Rank Sector Weight
1 Technology 22.54%
2 Healthcare 10.8%
3 Consumer Discretionary 9.19%
4 Financials 8.28%
5 Communication Services 7.91%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TARA icon
5101
Protara Therapeutics
TARA
$234M
$5K ﹤0.01%
+1,807
New +$6.61K
TOP icon
5102
TOP Financial Group
TOP
$1.36B
$5K ﹤0.01%
+42
New +$5.72K
TUR icon
5103
iShares MSCI Turkey ETF
TUR
$221M
$5K ﹤0.01%
286
-83
-22% -$1.76K
UCO icon
5104
ProShares Ultra Bloomberg Crude Oil
UCO
$422M
$5K ﹤0.01%
120
VCIT icon
5105
Vanguard Intermediate-Term Corporate Bond ETF
VCIT
$67.8B
$5K ﹤0.01%
63
-167
-73% -$13.6K
VEEE icon
5106
Twin Vee PowerCats
VEEE
$6.8M
$5K ﹤0.01%
+5
New +$6.16K
VFH icon
5107
Vanguard Financials ETF
VFH
$14B
$5K ﹤0.01%
66
-91,631
-100% -$7.74M
VRP icon
5108
Invesco Variable Rate Preferred ETF
VRP
$3.01B
$5K ﹤0.01%
226
+2
+0.9% +$47
VVOS icon
5109
Vivos Therapeutics
VVOS
$4.23M
$5K ﹤0.01%
140
-12
-8% -$499
VWOB icon
5110
Vanguard Emerging Markets Government Bond ETF
VWOB
$6.25B
$5K ﹤0.01%
+81
New +$5.25K
YARW
5111
Yarrow Bioscience, Inc. Common Stock
YARW
$115M
$5K ﹤0.01%
13
+5
+63% +$2.1K
WALD icon
5112
Waldencast
WALD
$169M
$5K ﹤0.01%
+504
New +$4.98K
WATT icon
5113
Energous
WATT
$83M
$5K ﹤0.01%
9
-38
-81% -$23.1K
WCBR
5114
WisdomTree Cybersecurity Fund
WCBR
$126M
$5K ﹤0.01%
+294
New +$6.01K
WULF icon
5115
TeraWulf
WULF
$8.09B
$5K ﹤0.01%
+4,398
New +$16.5K
XFOR icon
5116
X4 Pharmaceuticals
XFOR
$430M
$5K ﹤0.01%
188
-135
-42% -$5.13K
CIRC
5117
Circle8 Group
CIRC
$61.2M
$5K ﹤0.01%
173
+120
+226% +$4.38K
PHLT
5118
DELISTED
Performant Healthcare Inc
PHLT
$5K ﹤0.01%
1,775
+1,675
+1,675% +$4.16K
SPRB
5119
Spruce Biosciences
SPRB
$142M
$5K ﹤0.01%
40
-31
-44% -$3.97K
DXYN
5120
DELISTED
Dixie Group Inc
DXYN
$5K ﹤0.01%
3,908
+2,596
+198% +$5.82K
WKME
5121
DELISTED
WalkMe Ltd. Ordinary Shares
WKME
$5K ﹤0.01%
533
+108
+25% +$1.34K
NBST
5122
DELISTED
Newbury Street Acquisition Corporation Common Stock
NBST
$5K ﹤0.01%
+491
New +$4.79K
TRON
5123
DELISTED
Corner Growth Acquisition Corp. 2 Class A Ordinary Share
TRON
$5K ﹤0.01%
+544
New +$5.44K
HEWG
5124
DELISTED
iShares Currency Hedged MSCI Germany ETF
HEWG
$5K ﹤0.01%
+204
New +$5.74K
BTEC
5125
DELISTED
Principal Exchange-Traded Funds Principal Healthcare Innovators ETF
BTEC
$5K ﹤0.01%
163
-1
-0.6% -$33

Similar funds

Tower Research Capital (TRC)'s Q2 2022 Portfolio in Review

As of Q2 2022, Tower Research Capital (TRC) held 7,134 positions worth $4.46B, down 57% from $10.5B the previous quarter. Its ten largest holdings account for 21% of the portfolio.

Tower Research Capital (TRC) withdrew a net $4.51B in Q2 2022, closing 739 positions and reducing 2,324 holdings. Its most notable exit was iShares MSCI USA Value Factor ETF, an estimated $13.8M position sold in full.

By sector, the portfolio is most concentrated in Technology at 23% of assets, down from 31% a quarter earlier, followed by Healthcare and Consumer Discretionary.

Against the trend, Tower Research Capital (TRC) opened a new position in iShares Russell 1000 Value ETF worth $23.4M.

  • Tower Research Capital (TRC)'s largest Q2 2022 buy was iShares Russell 1000 Value ETF: 161,690 shares worth $23.4M.
  • Tower Research Capital (TRC) added most to iShares Russell 2000 ETF in Q2 2022, an estimated $41.1M increase.
  • Tower Research Capital (TRC)'s biggest Q2 2022 reduction was Apple, cutting an estimated $411M.
  • Tower Research Capital (TRC) fully exited iShares MSCI USA Value Factor ETF in Q2 2022, selling an estimated $13.8M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 21% of its $4.46B portfolio in Q2 2022.
  • Tower Research Capital (TRC) opened 733 new positions and closed 739 in Q2 2022.
  • Tower Research Capital (TRC)'s portfolio value fell 57% quarter-over-quarter to $4.46B.

Based on Tower Research Capital (TRC)'s 13F filing for Q2 2022, filed 15 Aug 2022.